N-glycolylneuraminic acid as a carbohydrate cancer biomarker
One of the forms of aberrant glycosylation in human tumors is the expression of N-glycolylneuraminic acid (Neu5Gc). The only known enzyme to biosynthesize Neu5Gc in mammals, cytidine-5′-monophosphate-N-acetylneuraminic acid (CMAH), appears to be genetically inactivated in humans. Regardless, low lev...
Main Authors: | Jing Wang, Lucy K. Shewell, Christopher J. Day, Michael P. Jennings |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523323000293 |
Similar Items
-
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
by: Lucy K. Shewell, et al.
Published: (2022-03-01) -
Heterophile carbohydrate antigen N‐glycolylneuraminic acid as a potential biomarker in patients with hepatocellular carcinoma
by: Shuji Akimoto, et al.
Published: (2023-08-01) -
Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides
by: Anoopjit Singh Kooner, et al.
Published: (2019-08-01) -
N-Glycolylneuraminic Acid in Animal Models for Human Influenza A Virus
by: Cindy M. Spruit, et al.
Published: (2021-05-01) -
Characterization of an Aptamer Targeting Neu5Gc, as an Endogenous Pathogenic Factor Derived from Red Meat
by: Yuxi Guo, et al.
Published: (2024-03-01)